A Letter Concerning "Aducanumab: What about the Patient?" Gandy S. Ann Neurol 2022;91:732-733.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gandy S. A Letter Concerning "Aducanumab: What about the Patient?" Ann Neurol 2022;91:732-733.
PMID: 35178727